The Carotid Center

Filter Your Results

 

News

 

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

Societies Introduce VQI Vascular Ultrasound Registry

January 16, 2018 -- The Society for Vascular Ultrasound (SVU), Society for Vascular Surgery (SVS), and Medstreaming-M2S announced the development of the Vascular Quality Initi…

Thirty-Day EMBOLDEN Data Evaluate the Gore Embolic Filter for CAS

January 16, 2018 -- The 30-day results from the EMBOLDEN clinical study were published by William A. Gray, MD, et al online in Catheterization and Cardiovascular Interventions…

Analysis of ACT 1 Shows Carotid Stent Fractures Are Not Associated With Adverse Events

January 2, 2018 -- Findings from a study that sought to report the stent fracture rate and its association with in-stent restenosis and adverse outcomes in ACT 1 asymptomatic …

Rivaroxaban With or Without Aspirin Evaluated in Patients With Stable Peripheral or Carotid Artery Disease

December 6, 2017 -- Findings from the company-sponsored COMPASS trial of rivaroxaban (Xarelto, Bayer AG and Janssen Research & Development, LLC) administered with or witho…

Preliminary 2-Year PARADIGM 101 Results Presented for InspireMD's CGuard EPS

December 5, 2017 -- InspireMD announced the preliminary 24-month follow-up results from the PARADIGM 101 clinical study utilizing the company's CGuard embolic protection s…

InspireMD Expands Pacific Rim Distribution Network for Its CGuard EPS

December 4, 2017 -- InspireMD, an Israeli-based developer of embolic prevention systems (EPSs)/thrombus management technologies and neurovascular devices, announced that …

Updated TCAR Data Presented From Silk Road Medical’s ROADSTER 1 and 2 Studies

November 29, 2017 -- Silk Road Medical, Inc. announced data from the ROADSTER 1 and 2 trials demonstrating the safety and efficacy of the company’s Enroute transcarotid …

 

advertisement

2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.